Ludwig Jeffrey Jerome 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-02-12+27,067→ 127,037 total - Award
Stock Option (Right to Buy)
2024-02-12+37,466→ 37,466 totalExercise: $6.36Exp: 2034-02-11→ Common Stock (37,466 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.
- [F2]Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.